Hepatic Steatosis After Neoadjuvant Chemotherapy for Pancreatic Cancer: Incidence and Implications for Outcomes After Pancreatoduodenectomy

BACKGROUND: This study aimed to determine the incidence of new onset hepatic steatosis after neoadjuvant chemotherapy for pancreatic cancer and its impact on outcomes after pancreatoduodenectomy. METHODS: Retrospective review identified patients who received neoadjuvant chemotherapy for pancreatic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Flick, K. F., Al-Temimi, M. H., Maatman, T. K., Sublette, C. M., Swensson, J. K., Nakeeb, A., Ceppa, E. P., Nguyen, T. K., Schmidt, C. M., Zyromski, N. J., Tann, M. A., House, M. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
SSAT Plenary Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363010/
https://www.ncbi.nlm.nih.gov/pubmed/32671796
http://dx.doi.org/10.1007/s11605-020-04723-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363010/
https://www.ncbi.nlm.nih.gov/pubmed/32671796
http://dx.doi.org/10.1007/s11605-020-04723-2

Ejemplares similares